Exciting new changes to the SBIR Program

0 SBIR Grant Applications with Business Clients

Now, unlike previously, companies can directly apply for SBIR (not STTR) Phase II funds having previously demonstrated Phase I-equivalent success! This stretches over all SBIR funding agencies (NIH, Department of Defense, and Department of Education). The NCI has just released it’s Direct to Phase II Pilot Program, under PAR-14-088. Next deadline: April 5, 2014. To […]

Read more

The NCI has Provocative Questions!

0 Uncategorized

The NCI is asking investigators to consider new and innovative research directions, through its release of its Provocative Questions Initiative. Topics are organized into groups (Group A through E) and range from tumor imaging/biology to clinical implementation. Investigators can apply for either R01 or R21 applications, but a Letter of Intent is mandatory and is […]

Read more

2014 NIH/CDC SBIR/STTR Topics Released!

0 Uncategorized

The 2014 topics for the SBIR/STTR program from the NIH and the CDC has just been released (PHS 2014-1). Of note, the NCI has announced its allocation of $5M to cover 8 new topics, ranging from chemotherapeutics/radiation modulators to a biosensor-based core needle tumor biopsy device. Also of interest, the National Heart, Lung, and Blood […]

Read more

Synergizing Omic and Symptom Science (R01)

0 Uncategorized

This new, exciting grant announcement from the NIH (the National Institute of Nursing Research, NINR) is structured as an R01 mechanism, but seeks research that bridges the gap between BIG DATA biological research (i.e., “-omics”) and patient-centered outcomes (e.g., symptoms, quality of life, etc.)—much akin to the new patient-centered PCORI priorities we see coming along. […]

Read more